诊断肝硬化时较大的年龄和较高的体重指数，与HCC的发生存在阴性相关。
An older age at time of cirrhosis diagnosis and a higher BMI were negatively associated with the development of HCC.
目的观察肝硬化患者血浆降钙素基因相关肽(CGRP)和内皮素(ET1)含量变化。
Objective to investigate the levels of plasma calcitonin gene related peptide (CGRP) and endothelin 1 (ET 1) in liver cirrhosis.
克利夫兰临床部的研究明确了NASH相关性肝硬化，是进展为HCC的一个很重要的危险因素，强于以前我们对其的认识。
The Cleveland Clinic study established that NASH-induced cirrhosis is a much greater risk factor for HCC than previously thought.
目的：对相关文献进行一项系统综述，来确定HCV相关性代偿期肝硬化的结局。
Aim to perform a systematic review of the literature to establish the outcome of compensated HCV cirrhosis.
目的探讨肝硬化及食管静脉曲张与血浆降钙素基因相关肽(cgrp)的关系。
Objective to investigate the relationship between esophageal varices and plasma calcitonin gene related peptide (CGRP) in liver cirrhosis.
结论16层螺旋CT能准确地测量肝脏及各肝叶的体积，肝硬化肝脏的大小与疾病的严重程度相关。
Conclusion The 16 slices helical CT can measure the hepatic lobes accurately, the changes of the hepatic lobes volume are correlated with the severity of liver cirrhosis.
研究结果显示：有三个因素与NASH相关性肝硬化组肝细胞癌的发生存在统计学意义。
Results indicate three factors that are statistically significant in the development of HCC within the NASH-cirrhosis group.
目的探讨维生素D受体（VDR）基因多态性与中国人自身免疫性肝炎（AIH）和原发性胆汁性肝硬化（PBC）发病的相关性。
Objective To study the association between the polymorphisms of vitamin D receptor (VDR) gene and autoimmune liver diseases and (AIH) and primary biliary cirrhosis (PBC) in Chinese.
目的观察肝硬化患者血浆一氧化氮(NO)和内毒素的水平，并分析其相关性。
Objective to observe the levels of plasma NO and endotoxin in cirrhosis patients and analyse their correlation.
目的探讨腺嘌呤易位体3（ANT 3）基因表达水平与原发性胆汁性肝硬化（PBC）的相关性。
To explore the correlation of adenine nucleotide translocator 3(ANT3) gene expression level with primary biliary cirrhosis(PBC).
结论慢性丙型肝炎患者中普遍存在自身免疫现象，自身抗体的检出率与患者的年龄和肝硬化发生率明显相关。
ConclusionThe autoimmune manifestations are existed commonly in patients with chronic hepatitis C. The positive rate of autoantibody is correlated with age and cirrhosis.
目的探讨垂体-甲状腺轴激素指标与肝炎后肝硬化中医证型的相关性。
Objective To identify the correlativity between pituitary-thyroid axis hormones and TCM syndromes in patients with hepatitis cirrhosis.
目的分析肝炎肝硬化门静脉高压症脾切除术后门静脉系统形成血栓的相关因素，寻找预防门静脉高压症脾切除术后门静脉系统形成血栓的方法。
Objective to analyze the relevant factors and explore methods for prevention of portal vein thrombosis in patients after splenectomy for portal hypertension due to cirrhosis resulting from hepatitis.
这种情况与降低的健康并发症风险相关，至少在没有肝硬化的那些人中。
Such a scenario is associated with a reduced risk of health complications, at least among those who do not already have cirrhosis.
目的：探讨幽门螺杆菌感染对肝硬化患者肝功能相关指标的影响。
Objective: To explore the effect of helicobacter pylori infection on liver function in patients with cirrhosis HB.
有些研究也发现了咖啡消费量与肝酶浓度存在逆相关，这也指出了患肝病和肝硬化的一个危险因素。
Several studies have found an inverse relationship between coffee consumption and liver enzymes levels that indicate a risk of chronic liver disease and cirrhosis.
目的：通过磁共振弥散加权成像(MR -DWI)与肝硬化程度的相关性研究，探讨其在评价肝硬化程度方面的价值。
Objective: To find the relation between MR diffusion weighted imaging (MR-DWI) and severity of hepatic cirrhosis, and study the value of MR-DWI in evaluating the severity of hepatic cirrhosis.
目的：探讨肝硬化血清甲状腺素水平与肝硬化病变程度及血清层粘蛋白浓度的相关性。
Objective: To explore the interrelation between serum thyroxine and laminin in patients with liver cirrhosis.
监测的有效性依赖于肝功能状态，而肝功能则影响治疗方式的选择和肝硬化相关的死亡率。
Its effectiveness depends on liver function, which affects the feasibility of treatments and cirrhosis-related mortality.
这些数据表明，NASH患者发生HCC的风险性，与HCV相关性肝硬化患者发生肝细胞癌的风险性相当。
These figures suggest that NASH carries a risk of HCC that rivals the risk in patients with HCV-cirrhosis.
瘦素与肝硬化患者的胰岛素抵抗相关。
前言：目的：了解肝硬化并发消化道出血的相关危险因素，为预防和控制上消化道出血提供可靠的依据。方法：对150例肝硬化患者进行病例对照研究。
Objective: to find out the related risk factors of cirrhosis complicated hemorrhage of upper digestive tract and provide reliable basis for preventing and controlling the disease.
这种预防效应推测可能与干扰素抗炎作用以及减缓肝硬化进程的作用相关。
This preventive effect may be speculated to be due to anti-inflammatory effect on persistent necro-inflammation and blocking progression of fibrosis in liver.
这种预防效应推测可能与干扰素抗炎作用以及减缓肝硬化进程的作用相关。
This preventive effect may be speculated to be due to anti-inflammatory effect on persistent necro-inflammation and blocking progression of fibrosis in liver.
应用推荐